Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug–metabolite atlas

Jun Liu*, Lies Lahousse, Michel G. Nivard, Mariska Bot, Lianmin Chen, Jan Bert van Klinken, Carisha S. Thesing, Marian Beekman, Erik Ben van den Akker, Roderick C. Slieker, Eveline Waterham, Carla J.H. van der Kallen, Irene de Boer, Ruifang Li-Gao, Dina Vojinovic, Najaf Amin, Djawad Radjabzadeh, Robert Kraaij, Louise J.M. Alferink, Sarwa Darwish MuradAndré G. Uitterlinden, Gonneke Willemsen, Rene Pool, Yuri Milaneschi, Diana van Heemst, H.E. Suchiman, Femke Rutters, Petra J.M. Elders, Joline W.J. Beulens, Amber A.W.A. van der Heijden, Marleen M.J. van Greevenbroek, Ilja C.W. Arts, Gerrit L.J. Onderwater, Arn M.J.M. van den Maagdenberg, Dennis O. Mook-Kanamori, Thomas Hankemeier, Gisela M. Terwindt, Coen D.A. Stehouwer, Johanna M. Geleijnse, Leen M. ‘t Hart, Eline P. Slagboom, Ko Willems van Dijk, Alexandra Zhernakova, Jingyuan Fu, Brenda W.J.H. Penninx, Dorret I. Boomsma, Ayşe Demirkan, Bruno H.C. Stricker, Cornelia M. van Duijn*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug–metabolite atlas'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds